Strategies used to reduce harms associated with fentanyl exposure among rural people who use drugs: multi-site qualitative findings from the rural opioid initiative
- PMID: 39182116
- PMCID: PMC11344336
- DOI: 10.1186/s12954-024-01062-2
Strategies used to reduce harms associated with fentanyl exposure among rural people who use drugs: multi-site qualitative findings from the rural opioid initiative
Abstract
Aim: Illicitly manufactured fentanyl and its analogs are the primary drivers of opioid overdose deaths in the United States (U.S.). People who use drugs may be exposed to fentanyl or its analogs intentionally or unintentionally. This study sought to identify strategies used by rural people who use drugs to reduce harms associated with unintentional fentanyl exposure.
Methods: This analysis focused on 349 semi-structured qualitative interviews across 10 states and 58 rural counties in the U.S conducted between 2018 and 2020. Interview guides were collaboratively standardized across sites and included questions about drug use history (including drugs currently used, frequency of use, mode of administration) and questions specific to fentanyl. Deductive coding was used to code all data, then inductive coding of overdose and fentanyl codes was conducted by an interdisciplinary writing team.
Results: Participants described being concerned that fentanyl had saturated the drug market, in both stimulant and opioid supplies. Participants utilized strategies including: (1) avoiding drugs that were perceived to contain fentanyl, (2) buying drugs from trusted sources, (3) using fentanyl test strips, 4) using small doses and non-injection routes, (5) using with other people, (6) tasting, smelling, and looking at drugs before use, and (7) carrying and using naloxone. Most people who used drugs used a combination of these strategies as there was an overwhelming fear of fatal overdose.
Conclusion: People who use drugs living in rural areas of the U.S. are aware that fentanyl is in their drug supply and use several strategies to prevent associated harms, including fatal overdose. Increasing access to harm reduction tools (e.g., fentanyl test strips, naloxone) and services (e.g., community drug checking, syringe services programs, overdose prevention centers) should be prioritized to address the polysubstance-involved overdose crisis. These efforts should target persons who use opioids and other drugs that may contain fentanyl.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
References
-
- Gumas ED, Baumgartner JC. “U.S. Overdose Deaths Remain Higher Than in Other Countries — How Harm-Reduction Programs Could Help. To the Point (blog), Commonwealth Fund, June 22, 2023. 10.26099/0eb5-9d85
-
- Hedegaard H, Miniño A, Spencer MR, Warner M. Drug overdose deaths in the United States, 1999–2020. NCHS data brief. 2022(428). - PubMed
-
- Spencer MR, Miniño AM, Warner M. Drug overdose deaths in the United States, 2001–2021. NCHS Data Brief. 2022;457:1–8. - PubMed
-
- Centers for Disease Control and Prevention. National Vital Statistics System. Provisional Drug Overdose Death Counts. Accessed: https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm
Publication types
MeSH terms
Substances
Grants and funding
- UH3 DA044830/DA/NIDA NIH HHS/United States
- UG3 DA044831/DA/NIDA NIH HHS/United States
- 5UH3DA044826/DA/NIDA NIH HHS/United States
- 5UH3DA044822/DA/NIDA NIH HHS/United States
- 5UH3DA044798/DA/NIDA NIH HHS/United States
- UH3 DA044798/DA/NIDA NIH HHS/United States
- UG3 DA044798/DA/NIDA NIH HHS/United States
- K01DA053159/DA/NIDA NIH HHS/United States
- 4UH3DA044829-03/DA/NIDA NIH HHS/United States
- 4UH3DA044380/DA/NIDA NIH HHS/United States
- U24DA048538/DA/NIDA NIH HHS/United States
- UH3DA044823/DA/NIDA NIH HHS/United States
- UH3DA044830/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical